Annual report pursuant to Section 13 and 15(d)

Stockholders' (Deficit) Equity - Stock Options (Details)

v3.20.4
Stockholders' (Deficit) Equity - Stock Options (Details) - USD ($)
12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Number of
Shares      
Outstanding, Number of Shares, beginning of period (in shares) 2,883,550 2,235,000  
Granted (in shares) 1,036,000 648,550  
Outstanding, Number of Shares, end of period (in shares) 3,919,550 2,883,550 2,235,000
Exercisable, Number of Shares (in shares) 1,627,425    
Weighted
Average
Exercise Price      
Outstanding, Weighted Average Exercise Price, beginning of period (in dollars per share) $ 2.70 $ 1.74  
Granted, Weighted Average Exercise Price (in dollars per share) 9.38 6.03  
Outstanding, Weighted Average Exercise Price, end of period (in dollars per share) 4.47 $ 2.70 $ 1.74
Exercisable, Weighted Average Exercise Price (in dollars per share) $ 2.47    
Outstanding, Weighted Average Remaining Life (Year) 8 years 1 month 9 days 8 years 7 months 13 days 9 years 5 months 8 days
Exercisable, Weighted Average Remaining Life (Year) 7 years 7 months 2 days    
Outstanding, Aggregate Intrinsic Value $ 13,095,054 $ 23,861,981 $ 23,100
Exercisable, Aggregate Intrinsic Value $ 8,696,368